Cranbrook Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cranbrook Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$308K	Sell	585 -26	-4%	-$14.6K	0.06%	110
2026 Q1	$343K	Hold	611	–	–	0.07%	100
2025 Q4	$413K	Buy	611 +240	+65%	+$163K	0.08%	92
2025 Q3	$237K	Hold	371	–	–	0.05%	120
2025 Q2	$199K	Hold	371	–	–	0.04%	118
2025 Q1	$156K	Sell	371 -11	-3%	-$4.78K	0.04%	123
2024 Q4	$158K	Buy	382 +25	+7%	+$11K	0.04%	123
2024 Q3	$180K	Hold	357	–	–	0.04%	116
2024 Q2	$174K	Buy	+357	New	+$179K	0.04%	114

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cranbrook Wealth Management's IDXX Position: Q2 2026 in Review

Cranbrook Wealth Management reduced its Idexx Laboratories (IDXX) stake by 4.3% in Q2 2026, selling an estimated $14.6K and leaving 585 shares worth $308K. The position accounts for 0.06% of the portfolio, ranked #110.

Cranbrook Wealth Management first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $413K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Cranbrook Wealth Management held 585 shares of Idexx Laboratories worth $308K as of Q2 2026.
Cranbrook Wealth Management sold 26 Idexx Laboratories shares in Q2 2026, an estimated $14.6K.
Idexx Laboratories made up 0.06% of Cranbrook Wealth Management's portfolio in Q2 2026, its #110 holding.
Cranbrook Wealth Management first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
Cranbrook Wealth Management's Idexx Laboratories position peaked at $413K in Q4 2025.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.